Product image of Nimbex (Cisatracurium Besilate) supplied by GNH India

Nimbex

Active Ingredient:
Cisatracurium Besilate
Origin:
EU

Nimbex (Cisatracurium Besilate)

Cisatracurium besilate, the active ingredient in Nimbex, is a non-depolarizing neuromuscular blocking agent presented as an injection solution for intravenous use. It produces skeletal muscle relaxation by competitively blocking nicotinic acetylcholine receptors, enabling safe endotracheal intubation, facilitating surgical muscle relaxation, and supporting patients on mechanical ventilation in intensive care settings.

GNH India supplies Nimbex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Manufacturer / TM Owner

Aspen Pharma Trading Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Cisatracurium besilate is a non‑depolarizing neuromuscular blocker that provides controlled skeletal muscle relaxation in peri‑operative and critical‑care settings.

  • Facilitation of endotracheal intubation: rapid muscle relaxation allows safe placement of the airway tube.
  • Skeletal muscle relaxation during surgery: enables optimal surgical conditions by eliminating involuntary movement.
  • Adjunct to mechanical ventilation: maintains ventilator synchrony in patients requiring prolonged respiratory support.

How It Works

  • Cisatracurium besilate acts as a competitive antagonist at nicotinic acetylcholine receptors located on the motor end‑plate of skeletal muscle. By preventing acetylcholine binding, it blocks depolarization of the muscle membrane, leading to a dose‑dependent, reversible relaxation of skeletal muscles without causing initial fasciculations.

Side Effects

Cisatracurium besilate may be associated with a range of adverse reactions, most of which are related to its pharmacologic action on neuromuscular transmission.

Common Side Effects

  • Transient hypotension: mild drop in blood pressure during infusion.
  • Flushing or erythema: skin reddening at the injection site.
  • Histamine release: occasional mild itching or rash.
  • Bradycardia: slower heart rate in susceptible patients.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction requiring immediate intervention.
  • Prolonged neuromuscular blockade: extended muscle weakness after discontinuation.
  • Respiratory depression: inadequate ventilation if not properly monitored.
  • Cardiac arrhythmias: irregular heart rhythms in high‑risk individuals.

Precautions & Warnings

When using cisatracurium besilate, clinicians should observe specific safety measures to minimize risks.

  • Monitor neuromuscular function: use peripheral nerve stimulators to assess depth of blockade.
  • Adjust dose in renal or hepatic impairment: clearance may be altered, requiring careful titration.
  • Avoid in patients with known hypersensitivity: discontinue immediately if allergic signs appear.
  • Caution in hemodynamically unstable patients: watch for hypotension and bradycardia.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the vial.

Avoid Interactions

Cisatracurium besilate can interact with other agents that influence neuromuscular transmission or cardiovascular stability.

Major Interactions (Avoid)

  • Aminoglycoside antibiotics (e.g., gentamicin): potentiate neuromuscular blockade and may cause prolonged paralysis.
  • Lithium therapy: enhances muscle relaxation and can lead to unexpected depth of blockade.

Moderate Interactions (Monitor Closely)

  • Inhalational anesthetics (e.g., sevoflurane): may increase the effect of cisatracurium, requiring dose adjustment.
  • Magnesium sulfate: can augment blockade, especially in obstetric patients.
  • Calcium channel blockers: may affect hemodynamic response during infusion.
  • Volatile anesthetics: synergistic effect on muscle relaxation, necessitating careful monitoring.

Frequently Asked Questions

Nimbex (cisatracurium besilate) is employed to produce skeletal muscle relaxation during surgical procedures, to facilitate safe endotracheal intubation, and as an adjunct to mechanical ventilation in intensive‑care settings. Its rapid onset and predictable duration make it valuable for controlled neuromuscular blockade in adult patients.

Cisatracurium besilate competitively blocks nicotinic acetylcholine receptors at the neuromuscular junction. By preventing acetylcholine from activating these receptors, it stops depolarization of the muscle membrane, resulting in a reversible, dose‑dependent relaxation of skeletal muscles without causing initial muscle fasciculations.

The dosing regimen for Nimbex is individualized and must be determined by the prescribing clinician based on the patient’s weight, clinical condition, and desired depth of neuromuscular blockade. Standard practice involves an initial bolus followed by titrated infusion, but exact amounts are set by the treating physician.

Safety data for cisatracurium besilate in pregnancy and lactation are limited. The drug should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and it is generally administered in controlled surgical or intensive‑care environments where alternatives may not be suitable.

To order Nimbex, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed), and import documentation.

Nimbex is a non‑depolarizing agent that undergoes Hofmann elimination, making its metabolism independent of renal or hepatic function, unlike agents such as rocuronium. This property offers more predictable clearance in patients with organ impairment, though onset may be slightly slower than some alternatives.

Nimbex should be stored at 2‑8 °C (refrigerated). Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution. Maintaining the cold‑chain ensures stability and potency of the injectable product.

Nimbex is supplied as a sterile injection solution for intravenous use. It is typically given as an initial bolus dose followed by a continuous infusion or intermittent dosing, administered by a qualified healthcare professional under continuous monitoring of neuromuscular function and vital signs.

The most critical risks include prolonged neuromuscular blockade leading to respiratory insufficiency, severe hypotension, anaphylactic reactions, and rare cardiac arrhythmias. Continuous monitoring of respiratory and cardiovascular status, as well as neuromuscular transmission, is essential to detect and manage these events promptly.

Nimbex should be avoided in patients with known hypersensitivity to cisatracurium or any component of the formulation. Caution is also advised for individuals with severe hemodynamic instability, uncontrolled cardiac arrhythmias, or those receiving interacting drugs such as aminoglycoside antibiotics without appropriate monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Cisatracurium Besilate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT